CurifyLabs is transforming personalized drug manufacturing through its digital and automated TailoredCure technology. We offer a Personalized Medicine as a Service concept for pharmacies, hospital pharmacies and veterinarians which saves time, delivers better and sustainable future treatments to patients.
Location: United States
Employees: 1-10
Total raised: $24.4M
Founded date: 2021
Investors 1
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.07.2026 | Series A | $14M | Lifeline V... |
| 02.06.2025 | - | $7.67M | - |
| 03.04.2023 | Grant | $2.72M | - |
Mentions in press and media 24
| Date | Title | Description |
| 07.08.2026 | Craft Health’s CraftMake Platform Gets a Peptide Test Run | Specialty pharmaceutical company PharmaTher Holdings is collaborating with Craft Health Pte. Ltd., a Singapore-based pharmaceutical technology company, to test whether Craft Health’s CraftMake 3D printing platform can produce personalized p... |
| 08.07.2026 | CurifyLabs Ignites Personalized Medicine Revolution with $14M US Expansion | CurifyLabs, a Finnish healthtech innovator, secured $14M in Series A funding. This capital fuels aggressive US expansion. The company automates pharmaceutical compounding with advanced 3D printing technology. This system personalizes medici... |
| 08.07.2026 | CurifyLabs Secures $14M to Bring Personalized Medicine to More Pharmacies | Helsinki-based health technology firm CurifyLabs has closed a $14 million Series A round to grow its automated system for producing personalized medications. The round was co-led by Sandwater and HealthCap, with Tesi and existing backers in... |
| 07.07.2026 | CurifyLabs Raises $14 Million Series A To Power Personalized Medicine | CurifyLabs announced that it has raised $14 million in Series A funding to expand its personalized medicine platform. The round was co-led by Sandwater and HealthCap, with participation from Tesi and existing investors, including Lifeline V... |
| 06.07.2026 | CurifyLabs bags €12M to automate personalised medicine | Finnish health technology company CurifyLabs has raised €12 million in a Series A funding round to expand its operations in the United States and accelerate the development of its platform for personalised medicine manufacturing. The round ... |
| 06.07.2026 | CurifyLabs Raises $14M in Series A Funding | CurifyLabs, a Helsinki, Finland-based healthtech startup that automates the process of pharmaceutical compounding, raised $14M in Series A funding. The round was led by Sandwater and HealthCap, with participation from Tesi, and existing inv... |
| 15.12.2025 | CurifyLabs Brings Personalized, Flavored 3D Printed Medications to Pets | CurifyLabs, a company developing 3D printing technology for compounded medications, has launched CuraBlend Vet, a veterinary excipient system designed to produce 3D printed, palatable, and personalized medications for pets. Developed for us... |
| 12.11.2025 | HealthTech Pioneer myTomorrows Lands $29M to Boost Global Patient Access | myTomorrows, a Dutch HealthTech innovator, just secured a $29 million investment from Avego. This capital injection propels its global mission. The company bridges the critical gap between emerging therapies and patients in need. Its AI-dri... |
| 11.11.2025 | As millions await approved therapies, myTomorrows strengthens its global patient-access mission with €25 million | myTomorrows, a Dutch HealthTech company that connects patients with possible pre-approval treatments, today announced the close of a €25 million financing in order to accelerate the global expansion of its AI-driven platform and enhance acc... |
| 24.10.2025 | CurifyLabs Launches CurifyLabs Create, a New Compounding Platform | CurifyLabs, a company developing 3D printing technology for compounded medications, has released its next-generation software platform, CurifyLabs Create. The system is designed to give pharmacists greater flexibility to design and modify f... |
Show more